GE HealthCare and Mayo Clinic Launch GEMINI-RT for Personalized Cancer Care
Rochester, Thursday, 4 December 2025.
GE HealthCare and Mayo Clinic’s GEMINI-RT initiative integrates imaging, AI, and patient monitoring to enhance radiation therapy, aiming to revolutionize cancer treatment through technology and interdisciplinary collaboration.
Introduction to GEMINI-RT
GE HealthCare and Mayo Clinic have launched GEMINI-RT, a pioneering collaboration that seeks to personalize radiation therapy by integrating cutting-edge imaging, artificial intelligence, and patient monitoring across the cancer care spectrum. Announced on December 2, 2025, this initiative is designed to transform cancer treatment through technological innovation and interdisciplinary teamwork [1][2].
The Four Pillars of GEMINI-RT
GEMINI-RT is structured around four core pillars: automation, predictive oncology, multimodal therapies, and connected care. Automation aims to streamline radiation therapy planning, reducing the time from days to minutes, which is a significant advancement in clinical efficiency [3]. Predictive oncology leverages AI to tailor treatment decisions, enhancing the precision of personalized care [4]. Multimodal therapies involve combining radiation with targeted drugs or precision heating to improve therapeutic outcomes [1]. Connected care tools utilize AI, biomarkers, and sensors for patient monitoring beyond the clinic, enabling early detection of side effects [2].
Impact on Cancer Treatment
The GEMINI-RT initiative promises to enhance clinical outcomes significantly. Radiation therapy is currently used in over 50% of cancer cases worldwide, affecting more than 2 million patients annually in the United States alone [1]. With a global cancer incidence of 19.3 million new cases in 2022, the demand for optimized radiation therapy is increasing [4]. This collaboration not only aims to improve the accuracy and effectiveness of treatments but also addresses clinician burnout by automating repetitive tasks and accelerating innovation in oncology care [3].
Collaborative Strengths and Future Prospects
The GEMINI-RT project builds on a strategic radiology research alliance formed between GE HealthCare and Mayo Clinic in 2023. Combining Mayo Clinic’s extensive clinical and research expertise with GE HealthCare’s technical and engineering capabilities in oncology, the partnership aims to shape the future of personalized radiation therapy [1][2]. This collaboration underscores the importance of integrating advanced technology in healthcare solutions, paving the way for more resilient and efficient cancer treatment protocols [3].